Research News

---

Topic: Hormonal Therapies (view all topics)

Tags for topic Hormonal Therapies:

• After surgery (also called "adjuvant")
• Arimidex
• Aromasin
• Aromatase Inhibitors
• Before surgery (also called "neoadjuvant")
• Evista
• Fareston
• Faslodex
• Femara
• Not applicable (no surgery)
• Planning Hormonal Therapy
• Prophylactic (to lower risk if you've never been diagnosed with breast cancer)
• Selective Estrogen Receptor Modulators
• Tamoxifen

View articles by month and year

• High-Risk Women Often Don’t Take Risk Reducing Medicines Because of Side Effects

  Published on May 7, 2013 at 5:32 am

  • Tags: Selective Estrogen Receptor Modulators, Evista, Tamoxifen, and Prophylactic (to lower risk if you've never been diagnosed with breast cancer)

  A report written for the U.S. Preventive Services Task Force says that many women at high risk of breast cancer don’t take medicines that can lower that risk because of side effects.

• Tamoxifen and Evista Both Good Choices to Reduce Risk

  Published on April 20, 2010 at 12:00 am

  • Tags: Evista, Tamoxifen, and Prophylactic (to lower risk if you've never been diagnosed with breast cancer)

  Both tamoxifen and Evista lower the risk of invasive and non-invasive breast cancer in women at high risk, and each medicine has benefits and risks.

• American Society Clinical Oncology Now Recommends Evista or Tamoxifen to Reduce Risk in High-Risk Women

  Published on May 26, 2009 at 12:00 am

  • Tags: Family History, Personal History of Breast Cancer, Evista, Tamoxifen, and Prophylactic (to lower risk if you've never been diagnosed with breast cancer)

  New guidelines from the American Society of Clinical Oncology (ASCO) now recommend both tamoxifen and Evista (chemical name: raloxifene) to reduce breast cancer risk in post-menopausal women at high risk.